September 29, 2023 10:17 AM EDT
News Briefing

Mer­ck KGaA's ex­pand­ed AI deal; As­cle­tis has new bio­mark­er da­ta for its PD-L1; De­ka clos­es $20M round

Ayisha Sharma

News Reporter

Anna Brown

News Reporter

Mer­ck KGaA con­tin­ues AI-pow­ered deal streak: Mer­ck KGaA has ex­pand­ed its col­lab­o­ra­tion with Is­raeli com­pa­ny Quris-AI, with an eye to iden­ti­fy­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

In sur­prise, study sug­gests Covid mR­NA vac­cines may boost can­cer im­munother­a­py ef­fi­ca­cy

Pfiz­er tees up Phase 3 test in weight man­age­ment — but in an un­ex­pect­ed area

Ex-Kite lead­ers step in at Kyver­na as CEO ex­its af­ter land­ing year's sec­ond-biggest IPO

BioN­Tech rolls out Phase 2 lung can­cer da­ta as VEGF bis­pecifics take cen­ter stage

Im­mat­ics los­es Bris­tol My­er­s' sup­port on Phase 1 bis­pe­cif­ic T cell en­gager

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times